Healthcare
Positron Corporation(POSC)
Live Price
Offline$1.82
+3.47% today
1Y Change
+16.23%
Window
Jun 23, 2025 โ Jun 15, 2026
- Market Cap
- $30.00M
- Revenue Growth
- -21.5%
- EPS Growth
- -270.0%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 23, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Positron Corporation (POSC) is a Healthcare stock with a market cap of $30.00M and listed on OTC. The stock last traded around $1.82 and up 16.2% across the available one-year price window (Jun 23, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of -21.5%, EPS growth of -270.0%, a dividend yield of 0.0%. What stands out right now is revenue -21.5%, EPS -270.0%, free cash flow -177.3% with operating margin -1962.1% and ROIC -307.5%. Valuation already assumes a fairly strong business story at price/sales 49.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines POSC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-21.5% vs +7.6% peer median
Operating Margin
Below sector median
-1962.1% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2025 was reported on Oct 28, 2025, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -21.5% and EPS is at -270.0%, with operating margin around -1962.1%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -6.3% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2025 Oct 28, 2025 | โ | +1.2% | -9.8% | -4.9% |
2025 May 15, 2025 | โ | +3.2% | -4.5% | -1.9% |
2015 Nov 23, 2015 | โ | +3.2% | -4.5% | -1.9% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
POSC
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
POSC Max Drawdown
-33.98%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for POSC and SPY.
Company Overview
Positron Corporation
Other OTC
Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.
- Leadership
- Adel Abdullah
- IPO Date
- Aug 9, 1999
- Employees
- 19
- Street Address
- 1777 Maryland Avenue
- Mailing
- Niagara Falls, NY, 14305
- Region
- Niagara Falls, NY, US
- Reporting Currency
- USD
- Investor Line
- 317 576 0183
- Last Updated
- May 3, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 49.2
- Price/Book
- 41.6
Growth
- Revenue
- -21.5%
- EPS
- -270.0%
- Free Cash Flow
- -177.3%
Profitability
- Gross Margin
- -384.7%
- Operating Margin
- -1962.1%
- Net Margin
- -1974.0%
- ROE
- -469.0%
- ROIC
- -307.5%
Balance Sheet
- Debt/Equity
- 1.35
- Current Ratio
- 1.39
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.